Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
Top Cited Papers
Open Access
- 1 May 2018
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 33 (5), 843-852.e4
- https://doi.org/10.1016/j.ccell.2018.03.018
Abstract
No abstract availableKeywords
Funding Information
- The Conquer Cancer Foundation of ASCO
- Bristol-Myers Squibb International Immuno-Oncology Network
- Geoffrey Beene Cancer Research Center
- Ludwig Trust
- Memorial Sloan Kettering Cancer Center (P30 CA008748)
- Parker Institute for Cancer Immunotherapy
- Druckenmiller Center for Lung Cancer Research
- Swim Across America
- Stand Up to Cancer-American Cancer Society Lung Cancer Dream Team Translational Research (SU2C-AACR-DT17-15)
- Bristol-Myers Squibb
- AstraZeneca
- Roche
- Genentech
- MedImmune
- Millennium Pharmaceuticals
- Eli Lilly
- Merck
- Celgene
- Biomarin
- Neon Therapeutics
This publication has 61 references indexed in Scilit:
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive MelanomaJournal of Clinical Oncology, 2013
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesNature Biotechnology, 2013
- Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparationNucleic Acids Research, 2013
- ContEst: estimating cross-contamination of human samples in next-generation sequencing dataBioinformatics, 2011
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumorsProceedings of the National Academy of Sciences, 2010
- The first 30 years of p53: growing ever more complexNature Reviews Cancer, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancersOncogene, 2002